Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthEquityFRA:2HE 93 Earnings Yield (Joel Greenblatt) % is 3.99% as of Jul. 2026, which is 159% above its 10-year median of 1.54. GuruFocus rates FRA:2HE with a GF Score™ of 93/100 and a GF Value™ of €92.70 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 680 Healthcare Providers & Services companies, HealthEquity ranks better than 51.76% on this metric.
HealthEquity's Enterprise Value for the quarter that ended in Jul. 2026 was €7,880 Mil.
HealthEquity's EBIT for the trailing twelve months (TTM) ended in Jul. 2026 was €311 Mil. HealthEquity's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jul. 2026 was 3.99%.
The historical rank and industry rank for HealthEquity's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
FRA:2HE'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -0.68 Med: 1.54 Max: 4.73
Current: 4.06
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of HealthEquity was 4.73%. The lowest was -0.68%. And the median was 1.54%.
FRA:2HE's Earnings Yield (Joel Greenblatt) % is ranked better than 51.76% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 3.785
vs FRA:2HE: 4.06
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. HealthEquity's Forward Rate of Return (Yacktman) % for the quarter that ended in Jul. 2026 was 21.46%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
HealthEquity Earnings Yield (Joel Greenblatt) % Related Terms
HealthEquity Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for HealthEquity's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, HealthEquity's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthEquity Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where HealthEquity's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
HealthEquitys Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jan. 2026 is calculated as
HealthEquity's EBIT for the trailing twelve months (TTM) ended in Jul. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €311 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 3.99% mean?
HealthEquity (FRA:2HE) has a Earnings Yield (Joel Greenblatt) % of 3.99% as of Jul. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on HealthEquity and its competitors. This is 159% above median its historical median of 1.54. According to the industry distribution chart, HealthEquity ranks #328 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 48.2%.
Is HealthEquity's Earnings Yield (Joel Greenblatt) % too high?
HealthEquity's current Earnings Yield (Joel Greenblatt) % of 3.99% is 159% above median its 10-year median of 1.54. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.79. HealthEquity's value of 3.99% is 5.4% above this industry median. Based on the distribution chart, HealthEquity ranks #328 out of 680 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, HealthEquity has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Earnings Yield (Joel Greenblatt) % compare to TXG and HNGE?
According to the Healthcare Providers & Services industry distribution chart, HealthEquity ranks #328 out of 680 companies for Earnings Yield (Joel Greenblatt) %. This puts HealthEquity in the upper half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.79. HealthEquity's value of 3.99% is 5.4% above this benchmark. While the company's 10-year median is 1.54 vs. the industry median of 3.79, HealthEquity has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.79, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthEquity's current Earnings Yield (Joel Greenblatt) % of 3.99% is 5.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on HealthEquity and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthEquity's current Earnings Yield (Joel Greenblatt) % is 3.99%, which is 159% above median its own 10-year median of 1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
Based on GuruFocus' analysis, HealthEquity (FRA:2HE) is currently considered Modestly Undervalued. The stock's GF Value™ is €92.70, compared to a current price of €82.50 — trading 11% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 3.99%, which is 159% above median its 10-year median of 1.54 and 5.4% above the Healthcare Providers & Services industry median of 3.79. HealthEquity's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Earnings Yield (Joel Greenblatt) % is 3.99% as of Jul. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthEquity (FRA:2HE) Overvalued in 2026?
Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued.
The current stock price of €82.50 is trading 11% below its estimated GF Value™ of €92.70.
GuruFocus considers HealthEquity to be Modestly Undervalued.
Key valuation signals for FRA:2HE:
Earnings Yield (Joel Greenblatt) %: 3.99% (159% above median its 10-year median of 1.54)
GF Value™: €92.70 vs. price of €82.50 (11% below fair value)
Industry Position: 5.4% above the Healthcare Providers & Services median (#328 of 680)
No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
93GF Score
Get the complete analysis for FRA:2HE
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2HE has been successfully added to your 
